Published in JAMA Neurol on January 01, 2015
International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology (2015) 6.64
MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome. J Neuroinflammation (2016) 1.20
Aquaporin-4 autoimmunity. Neurol Neuroimmunol Neuroinflamm (2015) 1.15
Neuromyelitis optica and the evolving spectrum of autoimmune aquaporin-4 channelopathies: a decade later. Ann N Y Acad Sci (2015) 1.07
Spinal cord MRI in multiple sclerosis--diagnostic, prognostic and clinical value. Nat Rev Neurol (2015) 1.01
Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders. Neurotherapeutics (2016) 0.91
Ultrahigh field MRI in clinical neuroimmunology: a potential contribution to improved diagnostics and personalised disease management. EPMA J (2015) 0.86
Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes. J Neurol (2015) 0.84
Clinical spectrum associated with MOG autoimmunity in adults: significance of sharing rodent MOG epitopes. J Neurol (2016) 0.79
Asymptomatic myelitis in neuromyelitis optica and autoimmune aquaporin-4 channelopathy. Neurol Clin Pract (2015) 0.77
Anti-N-methyl-D-aspartate receptor(NMDAR) antibody encephalitis presents in atypical types and coexists with neuromyelitis optica spectrum disorder or neurosyphilis. BMC Neurol (2017) 0.75
Multiple sclerosis and neuromyelitis optica spectrum disorders: some similarities in two distinct diseases. Neural Regen Res (2016) 0.75
Differential diagnosis of neuromyelitis optica spectrum disorders. Ther Adv Neurol Disord (2017) 0.75
Differential Diagnosis of Acute Myelopathies: An Update. Clin Neuroradiol (2015) 0.75
What's new in neuromyelitis optica? A short review for the clinical neurologist. J Neurol (2017) 0.75
Recurrent Longitudinally Extensive Myelitis and Aquaporin-4 Seronegativity - The Expanding Spectrum of Neuromyelitis Optica. J Clin Diagn Res (2017) 0.75
Severe aquaporin-4 IgG-positive neuromyelitis optica spectrum disorder with short myelitis lesion and favourable outcome. Neurol Sci (2015) 0.75
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol (2011) 25.66
Revised diagnostic criteria for neuromyelitis optica. Neurology (2006) 17.57
A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet (2004) 13.18
The clinical course of neuromyelitis optica (Devic's syndrome). Neurology (1999) 8.03
Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology (2002) 4.01
Serologic diagnosis of NMO: a multicenter comparison of aquaporin-4-IgG assays. Neurology (2012) 3.79
Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol (2006) 2.80
Aquaporin-4 antibody-positive cases beyond current diagnostic criteria for NMO spectrum disorders. Neurology (2013) 2.52
Neuromyelitis optica-IgG in childhood inflammatory demyelinating CNS disorders. Neurology (2007) 2.32
AQP4 antibody-positive Thai cases: clinical features and diagnostic problems. Neurology (2011) 1.77
Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder? Mult Scler (2012) 1.54
Neuromyelitis optica-IgG in idiopathic inflammatory demyelinating disorders amongst Hong Kong Chinese. Eur J Neurol (2009) 1.54
Epidemiology of neuromyelitis optica in the United States: a multicenter analysis. Arch Neurol (2012) 1.40
A benign form of neuromyelitis optica: does it exist? Arch Neurol (2011) 1.21
Painful tonic spasm in neuromyelitis optica: incidence, diagnostic utility, and clinical characteristics. Arch Neurol (2012) 0.99
Neuromyelitis optica IgG status in acute partial transverse myelitis. Arch Neurol (2006) 0.99
Evolution of longitudinally extensive transverse myelitis in an aquaporin-4 IgG-positive patient. Neurology (2013) 0.98
Aquaporin 4 IgG serostatus and outcome in recurrent longitudinally extensive transverse myelitis. JAMA Neurol (2014) 0.94
Modifications of longitudinally extensive transverse myelitis and brainstem lesions in the course of neuromyelitis optica (NMO): a population-based, descriptive study. BMC Neurol (2013) 0.94
NMO spectrum presenting as partial myelitis. Mult Scler (2012) 0.79
Comparison of relapse and treatment failure rates among patients with neuromyelitis optica: multicenter study of treatment efficacy. JAMA Neurol (2014) 1.27
Autoimmune aquaporin-4 myopathy in neuromyelitis optica spectrum. JAMA Neurol (2014) 1.00
Aquaporin 4 IgG serostatus and outcome in recurrent longitudinally extensive transverse myelitis. JAMA Neurol (2014) 0.94
Double Inversion Recovery Magnetic Resonance Imaging in Identifying Focal Cortical Dysplasia. Pediatr Neurol (2016) 0.87
Corticosteroid-Induced Paraplegia—A Diagnostic Clue for Spinal Dural Arterial Venous Fistula. JAMA Neurol (2015) 0.82
Moving targets for hematopoietic stem cell transplantation for multiple sclerosis. JAMA Neurol (2015) 0.75
Association of Extension of Cervical Cord Lesion and Area Postrema Syndrome With Neuromyelitis Optica Spectrum Disorder. JAMA Neurol (2017) 0.75
Positive neurologic phenomena with initiation of dalfampridine for multiple sclerosis. Mult Scler Relat Disord (2013) 0.75